Physician profile
Eric Kuhns
NPI 1699725549
$755.94
in general payments reported to CMS, 2019-2025
20 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $31.79 · 2022: $98.50 · 2023: $70.12 · 2024: $42.54 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $132.95 | 2025 | Korlym |
| Novo Nordisk INC | $106.45 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $83.01 | 2019-2020 | |
| Abbott Laboratories | $70.19 | 2022-2023 | Freestyle Libre 3 |
| Amgen INC. | $54.27 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $37.30 | 2019-2020 | |
| Medtronic USA, INC. | $28.92 | 2019 | |
| Pfizer INC. | $24.72 | 2019 | |
| Lilly USA, LLC | $24.43 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.28 | 2019 | |
| Eisai INC. | $23.28 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.34 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.03 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $18.11 | 2019 | |
| Glaxosmithkline, LLC. | $18.02 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17.84 | 2019 | |
| Medtronic, INC. | $15.75 | 2023 | Minimed 770g |
| Allergan, INC. | $13.53 | 2019 | |
| Shire North American Group INC | $11.93 | 2019 | |
| Merck Sharp & Dohme LLC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kuhns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.